**11.6 Development of compounds active against novel targets**

The sixth strategy is the most clinically tested and appealing modern chemotherapy strategy. It requires knowledge of genomics and proteomics methods that have the potential to speed up the detection of new drug targets and the subsequent discovery of molecules that function on these targets. The identification and characterisation of putative targets in a particular biochemical pathway for parasite growth is an urgent need to combat the disease, given the rapid emergence of drug resistance to traditional therapeutics. Our fast advancement in the characterisation of the genomes of malaria parasites suggests that this strategy is plausible to identify important new antimalarial compounds in the future. Because of our rapid progress in sequencing the genomes of malaria parasites, we conclude that this approach will be useful in discovering essential new antimalarial compounds in the future.
